High-Field MRI Iron-Based Contrast-Enhanced Characterization of Multiple Sclerosis and Demyelinating Diseases

NCT01973517 · clinicaltrials.gov ↗

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Logistical factors affecting recruitment

Conditions

Multiple Sclerosis

Interventions

DRUG: Feraheme
DRUG: Gadolinium-based contrast

Sponsor

Stanford University